Order Article Reprints

Inoue M-K, Yamamotoya T, Nakatsu Y, Ueda K, Inoue Y, Matsunaga Y, Sakoda H, Fujishiro M, Ono H, Morii K, et al. The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model. International Journal of Molecular Sciences. 2018; 19(12):3967. https://doi.org/10.3390/ijms19123967

Inoue, Masa-Ki, Takeshi Yamamotoya, Yusuke Nakatsu, Koji Ueda, Yuki Inoue, Yasuka Matsunaga, Hideyuki Sakoda, Midori Fujishiro, Hiraku Ono, Kenichi Morii, and et al. 2018. "The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model" International Journal of Molecular Sciences 19, no. 12: 3967. https://doi.org/10.3390/ijms19123967

Inoue, M.-K., Yamamotoya, T., Nakatsu, Y., Ueda, K., Inoue, Y., Matsunaga, Y., Sakoda, H., Fujishiro, M., Ono, H., Morii, K., Sasaki, K., Masaki, T., Suzuki, Y., Asano, T., & Kushiyama, A. (2018). The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model. International Journal of Molecular Sciences, 19(12), 3967. https://doi.org/10.3390/ijms19123967